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Abstract The major outer membrane lipoprotein (Lpp) of
Escherichia coli is released from the cytoplasmic membrane into
the periplasm as a complex with LolA, a periplasmic chaperone,
prior to the localization in the outer membrane. To determine
whether or not LolA is generally involved in the outer membrane
localization of lipoproteins in vivo, the chromosomal lolA gene
was manipulated so as to be controlled by the lac promoter-
operator. Depletion of LolA caused a severe growth defect, and
impaired the outer membrane localization of Lpp and Pal,
another outer membrane lipoprotein. Although LolA depletion
did not immediately arrest the growth of cells lacking Lpp,
disruption of the chromosomal lolA gene was lethal to the lpp3
strain, indicating that LolA is generally required for the outer
membrane localization of lipoproteins, and therefore essential
irrespective of the presence or absence of Lpp.
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1. Introduction
Many species of lipoproteins have been predicted to be
present in various microorganisms from the results of com-
plete genome sequencing. All lipoproteins are thought to be
synthesized with a signal peptide at the N-terminus and then
to be translocated across the inner (cytoplasmic) membrane in
a Sec machinery-dependent manner [1,2]. Cys residues at the
N-termini of mature lipoproteins are modi¢ed with lipids,
which function as an anchor to the membrane. Lipid modi¢-
cation and processing to mature lipoproteins in Escherichia
coli have been shown to take place in the inner membrane,
followed by their localization to either the inner or outer
membrane. The amino acid residue next to the lipid-modi¢ed
Cys functions as a sorting signal [3]. An Asp residue at this
position makes lipoproteins speci¢c to the inner membrane
whereas other residues direct lipoproteins to the outer mem-
brane.
The release of Lpp from the inner membrane of sphero-
plasts was found to require a periplasmic fraction, which led
to the identi¢cation of LolA as an Lpp releasing factor [4].
Inner membrane-speci¢c lipoproteins were found to remain
anchored to the inner membrane even in the presence of
LolA. These results indicate that LolA is a molecular chaper-
one speci¢c to the outer membrane lipoproteins. However, it
remains to be determined whether LolA alone is the lipopro-
tein-speci¢c chaperone or another chaperone exists for other
species of lipoproteins. To address this, we constructed an E.
coli mutant in which the chromosomal lolA gene is placed
under a controllable promoter. We report here that LolA is
a general chaperone for most, if not all, lipoproteins in E. coli.
2. Materials and methods
2.1. Materials
Restriction enzymes were purchased from Takara Shuzo. Isopropyl-
L-D-thiogalactopyranoside (IPTG) was from Sigma. Anti-LolA anti-
serum was prepared as described [4]. Anti-Pal antiserum was a gift
from T. Mizuno, Nagoya University. Tran35S label was obtained from
ICN.
2.2. Bacterial strains
E. coli FS1576 [5] and JE5505 [6] were used.
2.3. Construction of a plasmid carrying lolA under the control of the lac
promoter-operator
A 5.1 kb PstI fragment containing the lolA locus was isolated from
pMAN994 [4] and then cloned into the PstI site of pBR322 to con-
struct pTAN10. A synthetic DNA linker containing XhoI, BglII, SmaI
and XbaI sites was inserted into pTAN10 at the PvuI site, which is
located immediately upstream of the ribosome binding site of lolA, to
construct pTAN11. A 1.4 kb XhoI-BamHI fragment of pSY343 [7]
containing the kanamycin resistance gene (kan) was inserted into the
XhoI-BglII sites of pTAN11 to construct pTAN12. A 205 bp PvuII-
XbaI fragment of pUC19 [8] carrying the lac promoter-operator (lac-
PO) was inserted into the SmaI-XbaI sites of pTAN12. The plasmid
thus constructed, pTAN15, carries the lolA gene under the control of
lacPO (lac-lolA), the kan gene located upstream of lac-lolA in the
opposite direction, and the 5P- and 3P- chromosomal £anking regions
of lolA (Fig. 1A).
2.4. Construction of pTAN20
A DNA fragment containing the pal gene was ampli¢ed by poly-
merase chain reaction with a pair of primers (5P-TTACCAGTCGAC-
GAATTCAATAGTAAAGGAATCATTGAAATGCAACTG-3P and
5P-TCTCGACCCGGGCAATTCTCTTAGTAAACCAGTACCGCA-
CGA-3P) and the chromosomal DNA from MC4100, followed by
digestion with SalI and SmaI. The resultant fragment was inserted
into the SalI-SmaI site of pMAN885 [9] to construct pTAN20 carry-
ing pal under the control of the arabinose promoter.
2.5. Membrane localization of lipoproteins
The preparation of an envelope fraction, sucrose density gradient
centrifugation, SDS-polyacrylamide gel electrophoresis and £uorogra-
phy were carried out as described [4]. The immunoprecipitation of Pal
was performed according to the method described previously [10].
3. Results and discussion
3.1. Construction of an E. coli mutant carrying the
chromosomal lolA gene under the control of lacPO
To replace the chromosomal lolA gene with the lac-lolA
gene by homologous recombination, FS1576 (recD) was trans-
formed with pTAN15, which carries lac-lolA and which had
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been linearized by digestion with EcoRI and NheI (Fig. 1A).
Transformants were selected for resistance to 25 Wg/ml kana-
mycin on L-broth plates supplemented with 1 mM IPTG. One
of ¢ve kanamycin-resistant transformants, TT011, was used
for further analysis.
To con¢rm the genomic structure of the relevant region of
TT011, the chromosomal DNAs of FS1576 and TT011 were
digested with BglI and KpnI, and then subjected to Southern
hybridization analyses using a 0.76 kb HindIII-KpnI fragment
(probe 1) carrying most of the lolA gene (Fig. 1B). This probe
hybridized with a 2.2 kb fragment derived from FS1576 DNA
and a 3.7 kb fragment derived from TT011 DNA (Fig. 1C). A
TT011 DNA fragment of the same size hybridized with a 0.96
kb PstI fragment of the kan gene (probe 2), whereas no DNA
fragment derived from FS1576 hybridized with probe 2. These
results are consistent with the restriction map shown in Fig.
1B, suggesting that the lolA gene on the TT011 chromosome
was replaced by the lac-lolA gene together with kan.
3.2. Growth inhibition by LolA depletion in lpp+ cells
To determine whether or not the expression of lolA in
TT011 (lpp) is controlled by lacPO, the amounts of LolA
in TT011 cells grown in the presence and absence of 1 mM
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Fig. 1. Construction of lac-lolA mutant TT011. A: The structure of
pTAN15 used for the construction of TT011 is shown. Arrows indi-
cate the direction of the transcription. B: Restriction maps around
the chromosomal lolA locus of FS1576 (lolA) and TT011 (lac-lolA)
are shown. The 0.76 kb HindIII-KpnI fragment (probe 1) and 0.96
kb PstI fragment (probe 2) used for hybridization are also indi-
cated. C: The genomic structure containing the lolA locus of
FS1576 (lanes 1 and 3) and TT011 (lanes 2 and 4) was analyzed by
Southern hybridization using probes 1 and 2. Chromosomal DNAs
were digested with BglI and KpnI, and then analyzed on a 0.8%
agarose gel. Probe 1 (lanes 1 and 2) and probe 2 (lanes 3 and 4)
were labeled with biotin using an Amersham biotin-labeling kit. The
migration positions of DNA size markers are shown at the left.
Fig. 2. E¡ect of LolA depletion on the growth of TT011. A:
FS1576 (lane 1) and TT011 (lanes 2 and 3) were grown on L-broth
containing 1 mM IPTG at 30‡C. The cells were harvested, washed
three times with fresh L-broth containing no IPTG, and then grown
in L-broth with (lane 2) or without (lanes 1 and 3) 1 mM IPTG at
30‡C for 5 h. Cells were harvested and treated with 1% SDS at
100‡C for 5 min. Cellular proteins (80 Wg) were analyzed by SDS-
PAGE and immunoblotting with the anti-LolA antibody. B: TT011
was grown on L-broth with (open circles) or without (closed circles)
IPTG as described in A. Growth was followed by monitoring the
OD at 660 nm. The number of viable cells was determined on an
L-broth plate containing 1 mM IPTG.
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IPTG were determined by means of Western blotting with the
anti-LolA antibody (Fig. 2A). In the presence of IPTG,
TT011 cells produced a comparable amount of LolA to
FS1576 cells (lanes 1 and 2). In contrast, the cultivation of
TT011 cells for 5 h in the absence of IPTG reduced the
amount of LolA to an undetectable level (lane 3), indicating
that the lolA gene of TT011 is under the control of lacPO.
The depletion of LolA caused growth arrest and a decrease
in the number of viable cells (Fig. 2B), indicating that the
lolA gene is indispensable for the TT011 strain possessing
Lpp.
3.3. E¡ects of LolA depletion on the in vivo localization of Lpp
and Pal
To examine the in vivo role of LolA in the localization of
outer membrane lipoproteins, TT011 cells were grown in the
presence and absence of IPTG for 3 h, and then labeled with
Tran35S label for 1 min. An envelope fraction was prepared
from these cells and then subjected to fractionation by sucrose
density gradient centrifugation. The fraction prepared from
the cells grown in the absence of IPTG was not separated
into the inner and outer membranes. This was most likely
caused by the formation of a covalent linkage between Lpp
accumulated in the inner membrane and the peptidoglycan,
since an Lpp derivative, LppDK, possessing the inner mem-
brane sorting signal covalently attaches to the peptidoglycan
and thus prevents the membrane separation [9]. When the
synthesis of LppDK was induced for a short time, the mem-
brane separation was signi¢cantly improved as the association
of LppDK with the peptidoglycan was not signi¢cant [9]. We
therefore constructed the TT015 strain (lac-lolA lpp3) harbor-
ing pJY811 [9], which carries PBAD-lpp, by introducing the lac-
lolA gene into JE5505 (lpp3)/pJY811 by P1 transduction.
The TT015 strain harboring pJY811 was grown in the pres-
ence and absence of IPTG for 3 h. The cells were induced to
express lpp for 5 min by the addition of 0.1% arabinose and
then labeled with Tran35S label for 1 min, followed by a chase
with non-radioactive methionine and cysteine for 30 s. The
cell envelope fraction was prepared and then subjected to
sucrose density gradient centrifugation to fractionate the
membranes. Lpp was exclusively found in the outer mem-
brane fraction containing OmpA when TT015/pJY811 was
grown in the presence of IPTG (Fig. 3A). On the other
hand, Lpp was recovered in the inner membrane fraction of
the LolA-depleted cells (Fig. 3B), indicating that only LolA
among all periplasmic proteins is involved in the in vivo re-
lease of Lpp. We also examined the localization of Pal, an-
other outer membrane lipoprotein, in TT015 cells harboring
pTAN20 carrying PBAD-pal. The depletion of LolA also
caused the inner membrane localization of Pal (Fig. 3C).
However, this was only observed when Pal was labeled for
a short time. When expressed for a longer period, a substan-
tial portion of Pal was found in the outer membrane (data not
shown), suggesting that either the outer membrane localiza-
tion of Pal takes place at a slow rate due to incomplete de-
pletion of LolA or a factor substituting for the LolA function
exists.
3.4. Disruption of lolA in an lpp3 strain
TT011 (lac-lolA lpp) exhibited a severe growth defect in
the absence of IPTG (Fig. 2B), whereas strains such as TT015
(lac-lolA lpp3) lacking Lpp were found to grow normally even
in the absence of IPTG (data not shown). Furthermore, the
inner membrane accumulation of Pal in TT015 cells was ob-
served only when the cells were labeled for a short period. The
number of Lpp molecules in a single cell is several orders of
magnitude higher than those of other lipoproteins [11]. These
results therefore suggest that either lolA is essential for E. coli
only when lpp is expressed or an uninduced level of LolA is
su⁄cient for the release of other outer membrane lipopro-
teins. To address this, we attempted to construct an lpp null
mutant in the lpp3 background.
The kan gene was inserted into the NdeI site within the lolA
gene on pMAN994 to construct pTAN1001. FS1576 harbor-
ing pMAN995, which carries PBAD-lolA and an ampicillin
resistance gene, was transformed with pTAN1001 linearized
with EcoRI and ApaLI. Kanamycin-resistant transformants
were selected on L-broth plates supplemented with arabinose.
One of them, TT020, was found to harbor intact pMAN995.
Southern blot analysis of the chromosomal DNA from this
strain con¢rmed that the lolA gene was disrupted. The
lolA: :kan gene was then introduced into JE5505 (lpp3) by
P1 transduction. Although many tiny colonies appeared on
L-broth plates containing kanamycin, none of them could
continue to grow.
Taking all the results presented here together, we conclude
that the lipoprotein localization system involving LolA and
LolB [12] is essential for E. coli irrespective of the presence or
absence of Lpp. We therefore assume that an uninduced level
of LolA in TT015 is su⁄cient for the release of lipoproteins
including Pal since the cell lacks Lpp.
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Fig. 3. E¡ect of LolA depletion on the in vivo localization of Lpp
and Pal. TT015 harboring pJY811 (A and B) or pTAN20 (C) was
grown in M63 minimal medium [13] with or without 1 mM IPTG
at 30‡C for 3 h. The synthesis of Lpp and Pal was induced for
5 min by the addition of 0.1% arabinose. Lpp and Pal were labeled
in 1 ml of the culture with Tran35S label (10 WCi) for 1 min and
then chased by the addition of 12 mM each of methionine and cys-
teine for 30 s. The envelope fraction was prepared and then sub-
jected to sucrose density gradient (25^55%, w/w) centrifugation, fol-
lowed by fractionation into fractions 1^12, from the bottom to the
top of the gradient. Each fraction was analyzed by SDS-PAGE and
£uorography. Pal was analyzed after immunoprecipitation with an
anti-Pal antibody.
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